Sophia Quezada Higareda, PA-C

Sophia Higareda practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Sophia Higareda's NPI, 1558601369, was assigned on February 15, 2013. Sophia Higareda holds Texas license PA08295.

Sophia Higareda's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Sophia Higareda's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Sophia Higareda practices. Vendor and product names are available with a free account.

Physician assistant is Sophia Higareda's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Sophia Higareda is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Sophia Higareda is licensed in Texas.

Dmand AI lists enlarged prostate among the conditions Sophia Higareda treats.

CMS data shows 292 Medicare services from Sophia Higareda across 4 procedure codes in 2024, for 227 Medicare patients. Medicare paid $12,405 for them.

CMS counts 227 Medicare patients who saw Sophia Higareda in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sophia Higareda's median patient age at 76, with 29% women.

In 2024, Sophia Higareda wrote 11 Medicare Part D claims. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Sophia Higareda for performance year 2024, reported as part of a group. Sophia Higareda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sophia Higareda as offering telehealth.

CMS Open Payments shows 3 general payments to Sophia Higareda from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $119.